Toronto, Ontario–February 11, 2021) – Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) (“Relay” or the “Company“) is pleased to announce that the company has received proceeds of $3,018,331.63 from the exercise of 9,440,508 common share purchase warrants and 1,850,000 options. The exercise of these warrants and options has resulted in 11,290,508 common shares being issued. The proceeds will be used for general working capital purposes.
Relay Medical recently announced the closing of a private placement offering of over $8.5M to fund and accelerate the Company’ continued development and evolving/expanding commercial operations.
SUBSCRIBE: For more information on Relay or to subscribe to the Company’s mail list visit: https://www.relaymedical.com/news.
About Relay Medical Corp.
Relay Medical is a MedTech innovation Company headquartered in Toronto, Canada focused on the development of novel technologies in the diagnostics and AI data science sectors.
Website: www.relaymedical.com